| FBCIX | RAPCX | FBCIX / RAPCX | |
| Total Expense Ratio | 0.35 | 1.81 | 19% |
| Annual Report Gross Expense Ratio | 0.35 | 1.91 | 18% |
| Fund Existence | 6 years | 14 years | - |
| Gain YTD | 8.602 | 10.739 | 80% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 128B | 1.91B | 6,716% |
| Annual Yield % from dividends | 2.96 | 4.95 | 60% |
| Returns for 1 year | 10.68 | 18.15 | 59% |
| Returns for 3 years | 40.32 | 35.65 | 113% |
| Returns for 5 years | 42.79 | 36.70 | 117% |
| Returns for 10 years | N/A | 72.81 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NBIZ | 9.92 | 0.73 | +7.94% |
| Tradr 2X Short Nbis Daily ETF | |||
| EQRR | 80.77 | N/A | N/A |
| ProShares Equities for Rising Rates ETF | |||
| CPSU | 27.68 | -0.02 | -0.05% |
| Calamos S&P 500 Structured Alt Protection ETF - June | |||
| WTMF | 40.89 | -0.16 | -0.39% |
| WisdomTree Managed Futures Strategy ETF | |||
| IHE | 99.99 | -0.52 | -0.52% |
| iShares US Pharmaceuticals ETF | |||